Brussels - Delayed Quote EUR
Financière de Tubize SA (TUB.BR)
122.00
+1.80
+(1.50%)
At close: May 9 at 5:35:10 PM GMT+2
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Eric Nys | Managing Director | 185.63k | -- | -- |
| Ms. Anne Sophie Pijcke | General Manager | 37k | -- | -- |
Financière de Tubize SA
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Financière de Tubize SA operates as a mono holding company whose sole investment is a stake in UCB which is a biopharma company in Belgium. It engages in discovering and developing treatments for patients suffering from serious illnesses that affects immune system or central nervous system. The company was incorporated in 1928 and is based in Brussels, Belgium.
Corporate Governance
Financière de Tubize SA’s ISS Governance QualityScore as of May 1, 2025 is 9. The pillar scores are Audit: 10; Board: 10; Shareholder Rights: 2; Compensation: 5.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
August 2, 2025 at 10:59 AM UTC
Financière de Tubize SA Earnings Date
Recent Events
April 30, 2025 at 12:00 AM UTC
Ex-Dividend Date
Related Tickers
UCB.BR UCB SA
154.35
+1.78%
ARGX.BR argenx SE
496.00
+1.99%
ABRT.CN Albert Labs International Corp.
0.0050
0.00%
688428.SS InnoCare Pharma Limited
20.56
+0.54%
XUPB.F Genfit S.A.
3.7800
-0.53%
328.SG MeiraGTx Holdings PLC
4.8400
+0.83%
CSJA.F CSL Limited
66.50
0.00%
BSFAF BSF Enterprise Plc
0.0584
0.00%
25I.SG ImmuPharma PLC
0.0295
0.00%
6XC.F Soleno Therapeutics, Inc.
64.85
+1.25%